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Cbu.L1917, a group I intron present in the 23S rRNA gene of Coxiella burnetii, possesses a unique 3ⴕ-terminal
adenine in place of a conserved guanine. Here, we show that, unlike all other group I introns, Cbu.L1917
utilizes a different cofactor for each splicing step and has a decreased self-splicing rate in vitro.
Coxiella burnetii is an obligate intracellular gammaproteobacterium that causes Q fever in humans (3). In addition, C.
burnetii infects domestic ruminants and has been isolated from
a wide variety of wild vertebrates and arthropods (9). Inside
the host cell, C. burnetii replicates in a parasitophorous vacuole
that has features of a mature phagolysosome (20). Genome
sequences of four C. burnetii isolates have been published
recently and show diversity in their pseudogene content and
other pathoadaptive features (1, 18). Previously, we described
two highly conserved self-splicing group I introns in the 23S
rRNA gene of ten C. burnetii isolates belonging to eight genotypes (14, 15). Here, we present the unique self-splicing mechanism of one of the introns (Cbu.L1917), which is altered from
and slower than the canonical group I intron-splicing process
described to date.
Group I introns are ribozymes that catalyze a two-step transesterification reaction that results in a free intron and spliced
exons (21). All group I introns share conserved features such as
a secondary structure that consists of about 10 paired (P)
elements and their terminal nucleotide, which until the discovery of Cbu.L1917 was always a guanine (15). The conserved
terminal guanine (⍀G) plays an important role in group I
intron self-splicing. In the first splicing step, the 3⬘-OH group
of an exogenous guanosine bound to the G-binding site (GBS)
in P7 carries out a nucleophilic attack on the 5⬘ splice site to
release the 5⬘ end of the intron. The guanosine is now covalently attached to the free 5⬘ end of the intron and is removed from the GBS, allowing ⍀G to occupy the site and mark
the 3⬘ splice site. The second splicing step is chemically equivalent to the reverse of the first step, where the free 3⬘-OH
group of the 5⬘ exon attacks the 3⬘ splice site, releasing the
intron and leaving the exons spliced together (19). When we
first characterized Cbu.L1917 as a self-splicing intron by functional analyses, we were unclear about its classification as a
group I intron due to its unique 3⬘-terminal adenine (⍀A).
Since ⍀A marks the site for Cbu.L1917’s second splicing step,
we wanted to determine the cofactor used in its first splicing
step.
Genomic DNA was isolated from C. burnetii Nine Mile
phase II (RSA 439; clone 4) using a High Pure PCR template
preparation kit (Roche Diagnostics, Basel, Switzerland), and

the region coding for Cbu.L1917 and its flanking exons were
amplified using specific primers (L1917_flank, Table 1) by
PCR, as previously described (14). The amplicons were purified (QIAquick nucleotide removal kit; Qiagen, Valencia, CA)
and used as a template for in vitro transcription utilizing the T7
promoter sequence (underlined in L1917_flank, Table 1) and a
MEGAscript high-yield transcription kit (Ambion, Austin,
TX). The resulting RNA was electrophoresed in a 5% (wt/vol)
acrylamide-8 M urea gel, and the precursor RNA (unspliced
intron with flanking exons) was excised from the gel; eluted
overnight at 37°C into a buffer containing 0.5 M ammonium
acetate, 1 mM EDTA, and 0.1% sodium dodecyl sulfate; and
subsequently purified with an RNeasy minikit (Qiagen). In
vitro intron splicing was performed for 30 min at 37°C using 1
g of precursor RNA in a buffer containing 10 mM Tris-HCl,
pH 7.5, 50 mM KCl, 50 mM MgCl2, and 0.8 mM ribonucleoside triphosphate mix (0.2 mM each of rATP, rGTP, rCTP, and
rUTP). Unincorporated nucleotides were removed using a
NucAway kit (Ambion), and the spliced intron RNA (which has
the nucleotide cofactor used in the first splicing step covalently
attached to its 5⬘ end) was used as a template for cDNA
synthesis with a primer that nestles within the intron sequence
(L1917_internal, Table 1). Template RNA was removed by
RNase treatment, and the cDNA was tailed using terminal
deoxynucleotidyltransferase (5⬘ rapid amplification of cDNA
ends system; Invitrogen, Carlsbad, CA) and 2 mM dATP. The
tailed cDNA was purified (QIAquick nucleotide removal kit;
Qiagen) and PCR amplified using a primer that hybridizes to
the poly(A) tail and a primer complementary to a sequence
within the intron (L1917_tail, Table 1). The amplicons were
cloned into pCR2.1-TOPO using a TOPO TA cloning kit
(Invitrogen). Twenty random clones were sequenced with a
BigDye Terminator cycle sequencing ready reaction kit and
an automated DNA sequencer (ABI3130x1; ABI, Foster City,
CA). Sequencing results showed that all 20 clones had guanine
incorporated at the 5⬘ end of the intron RNA, revealing that
the cofactor used by Cbu.L1917 in its first splicing step is GTP.
To confirm the above observations, we performed in vitro
splicing in the presence of either GTP or ATP (Fig. 1). Unspliced precursor RNA (Cbu.L1917 with flanking exons) was
synthesized and purified as described above. In vitro splicing
was carried out with 2 g of precursor RNA and the same
buffer and reaction conditions as those described above, except
that 0.2 mM of either rATP or rGTP was provided along with
relevant controls (without essential MgCl2 or nucleotide cofactors). After the splicing reactions (37°C, 30 min), equal
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TABLE 1. PCR primers used in the study
Sequence
Designation
5⬘ primer
a

L1917_flank
L1917_internal
L1917_tail
L1917_mutb
a
b

3⬘ primer

TAATACGACTCACTATAGGGAGGTGGCTGCGACTGTTTAC
TATTGACGTTATGTTAATCATG
GGCCACGCGTCGACTAGTACTTTTTTTTTTTTTTTTT

GGAATTTCGCTACCTTAGGACCG
CGCTATAGAGATCGGACTC
GGAATTTCGCTACCTTAGGACCGTTCATTG

T7 promoter sequence is underlined.
Mutation site is in boldface.

volumes of gel loading buffer (Ambion) were added to the
RNA and heated at 95°C for 5 min to disrupt secondary structures. The samples were then electrophoresed in a 5% (wt/vol)
acrylamide-8 M urea gel (150 V, 60 min). The gel was stained
with ethidium bromide and visualized using a Gel Doc system
(Bio-Rad, Hercules, CA). As shown in Fig. 1, the intron splices
only in the presence of GTP but not ATP, confirming that GTP
is the cofactor in the first splicing step of Cbu.L1917.
Results from the above experiments demonstrate that, unlike all other group I introns studied to date, Cbu.L1917 uses
a different cofactor for each splicing step (guanine for the first
step and its terminal adenine for the second step). Earlier
studies showed that if the 3⬘-terminal guanine was mutated to
adenine, the efficiency of group I intron splicing was markedly
reduced (2, 10, 13). To investigate how the natural guanineto-adenine mutation observed in Cbu.L1917 affects its splicing
efficiency, we compared the rates of intron splicing between
wild-type Cbu.L1917(⍀A) and Cbu.L1917(⍀A3G).
During the first step of group I intron splicing, the nucleotide cofactor (guanosine, GMP, or GTP) is covalently linked to
the 5⬘ end of the intron (19). By using 35S-GTP in the splicing
reaction and quantifying its incorporation into spliced introns
at various time points, the rate of intron splicing can be calculated. To perform a comparative analysis, we first mutated the
terminal adenine to guanine using a PCR-based strategy. A
primer that replaces the terminal adenine with guanine
(L1917_mut, Table 1) and a primer with T7 promoter sequence (L1917_flank, 5⬘ primer, Table 1) were used in the
PCR. The amplicon with the T7 promoter region and the
⍀A-to-G mutation was used as the template for in vitro tran-

FIG. 1. Cbu.L1917 splices in the presence of GTP but not ATP.
Two micrograms of precursor unspliced intron RNA was spliced in the
presence of either 0.2 mM rGTP (lane 3) or 0.2 mM rATP (lane 4).
Splicing reaction mixtures without MgCl2 (lane 1) or without nucleotides (lane 2) were included as controls. RNA size standards are shown
to the left in bases.

scription using a MEGAscript kit (Ambion) to produce the
unspliced precursor RNA. The RNA was purified using an
acrylamide gel as described above, and 500 ng was used per
reaction. Splicing reactions were carried out as described
above but with 25 Ci of ␥-35S-GTP (Perkin-Elmer, Waltham,
MA). The reactions were started by the addition of 50 mM
MgCl2, and the samples were incubated at 37°C for either 2
min or 10 min. The reactions were stopped by chilling the
mixtures on ice and by adding 10 mM EDTA. Unincorporated
nucleotides were removed using an RNeasy minikit (Qiagen).
The RNA was mixed with scintillation cocktail (Aquasol-2;
Perkin-Elmer) and counted using a liquid scintillation system
(Beckman Coulter, Fullerton, CA). The amounts of 35S-GTP
incorporated into spliced introns are presented as counts per
minute (Fig. 2). The rate of splicing for each intron was determined from the slope (m) of the plots (8). As shown in Fig.
2, the slope of wild-type Cbu.L1917(⍀A) (m ⫽ 10.90 ⫾ 1.32) is
significantly lower (P ⫽ 0.015, paired t test) than that of
Cbu.L1917(⍀A3G) (m ⫽ 15.09 ⫾ 2.20). This observation is
consistent with earlier reports showing that when ⍀G of a
group I intron was mutated to adenine, it resulted in a significant loss in splicing efficiency (2, 10, 13).
The GBS binds an exogenous guanine during the first splicing step and then the terminal guanine during the second step

FIG. 2. Comparison of intron splicing rates. Cbu.L1917 with terminal adenine (⍀A) or terminal guanine (⍀G) was spliced in the
presence of ␥-35S-GTP. CPM recorded after 2- and 10-min incubations
were plotted, and the slopes were determined. One graph representative of three independent experiments is shown. The slope for
Cbu.L1917(⍀A) (filled circles, dashed line) is significantly lower than
that of Cbu.L1917(⍀A3G) (open circles, solid line) (P ⫽ 0.015, paired
t test).
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to facilitate group I intron self-splicing. The GBS has evolved
to accommodate guanine efficiently to the exclusion of other
nucleotides (10, 13). The guanine cofactor interacts with a
G 䡠 C base pair in the GBS to form a stable base triple (4, 19).
However, in the case of Cbu.L1917, the GBS is forced to
accommodate an adenine in place of guanine during the second splicing step. The resulting less-compatible binding of ⍀A
to GBS is likely the reason for the decreased splice rate exhibited by Cbu.L1917. In fact, earlier studies have shown that
when the G 䡠 C pair in GBS is mutated to A 䡠 U such that it
can efficiently accommodate ⍀A during intron splicing, the
rate of intron splicing is restored (2, 10). It is likely that some
C. burnetii proteins help Cbu.L1917 splice more efficiently in
vivo, thereby negating the deleterious effects of the ⍀G-to-A
mutation (7). Another possibility is that an intron with decreased splicing rate was fixed in C. burnetii due to genetic
drift.
The genomes of host-associated bacteria tend to be A⫹T
rich. Even though the mechanisms underlying this GC-to-AT
shift are not well understood, it is thought to be due to a
variety of factors like mutational bias, loss of DNA repair
genes, or metabolic cost (11, 16). The Coxiella chromosome
and Cbu.L1917 both have low G⫹C ratios (42.5% and 36.8%,
respectively). The terminal guanine might have mutated to an
adenine as part of the GC-to-AT conversion that occurred
during the evolution of C. burnetii from a free-living bacterium
to an obligate intracellular pathogen (14, 18).
Obligate intracellular bacteria are susceptible to genetic
drift due to constant availability of nutrients, low effective
population size, and bottlenecks during transmission, resulting
in stochastic loss of some beneficial genes and accumulation of
some slightly deleterious mutations (Muller’s ratchet) (11, 12).
This process has resulted in the accumulation of slightly deleterious mutations in such vital genes as groEL and 16S rRNA
in the obligate endosymbiotic bacterium Buchnera aphidicola
(5, 6) and gene decay and pseudogene formation in the facultative intracellular pathogen Francisella tularensis (17). Similarly, it is possible that the ⍀G-to-⍀A mutation in Cbu.L1917
that occurred during the evolution of C. burnetii was fixed in
the population in spite of the slightly deleterious loss in splicing rate.
We thank Patty McIntire (UM Murdock Sequencing Facility) for
sequence analyses.
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